External site

By following this link, you are leaving Medically and entering a website that is not owned or controlled by Roche. Roche does not take any responsibility for access to or use of this website, nor for any content therein.

Leave site
Home Inflammatory disease UEGW 2025
Roche and Genentech at

UEGW 2025

October 04 - October 07
Berlin, Germany / Virtual (Hybrid)
ueg.eu
Add to calendar
Share feedback
Share page
-
Medical Materials
Agenda
Coming soon
07:00 AM
Duration 8hrs Berlin, Germany
Baseline Characteristics Associated with Probability of Remission and Greater Absolute Benefit of Treatment with Afimkibart (RO7790121/RG6631)
Laurent Peyrin-Biroulet, Jessica R. Allegretti, Silvio Danese, Parambir S. Dulai, Anindita Banerjee, Deepa E. Chandra, Elena Peeva, Srividya Neelakantan, Michael S. Vincent, Kenneth Hung, Lyann Ursos,Courtney Schiffman, Daniela Bojic, Karen Lasch, Bruce E. Sands
Inflammatory Disease | Inflammatory Bowel Disease

You have successfully signed up for this alert. You will be notified when it is available.

Sign up or login to unlock the full suite of MEDICALLY features
Add to calendar
03:30 PM
Duration 60mins Berlin, Germany
Innovations in IBD Therapy: The Story of TL1A – from Discovery to Potential Future Care
Dr Jean-Frédéric Colombel, Dr Remo Panaccione, Dr Beatriz Gros
Inflammatory Disease | Inflammatory Bowel Disease

You have successfully signed up for this alert. You will be notified when it is available.

Sign up or login to unlock the full suite of MEDICALLY features
Add to calendar

This website is intended for healthcare professionals outside the United Kingdom (UK) and Australia. Registration status and prescribing information of medicinal products may differ between countries. Please refer to local product information for any medicinal products mentioned on this website.